Accuracy study on "Osteorisk": a new osteoporosis screening clinical tool for women over 50 years old

Detalhes bibliográficos
Autor(a) principal: Steiner,Marcelo Luis
Data de Publicação: 2008
Outros Autores: Fernandes,César Eduardo, Strufaldi,Rodolfo, Azevedo,Lucia Helena de, Stephan,Cristina, Pompei,Luciano Melo, Peixoto,Sérgio
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100005
Resumo: CONTEXT AND OBJECTIVE: Osteoporosis is the greatest cause of quality-of-life reductions, morbidity and mortality among postmenopausal women, with growing incidence as populations age. Clinical tools like Osteorisk provide an easy-access and low-cost alternative method that helps physicians to reduce the need for dual-energy X-ray absorptiometry (DXA), the expensive gold standard examination for diagnosing osteoporosis. The aim here was to study the accuracy of Osteorisk using heel ultrasonography for bone mineral density (BMD). DESIGN AND SETTING: Cross-sectional study, at Faculdade de Medicina do ABC. METHODS: A structured questionnaire was applied to 615 postmenopausal women, with anthropometric measurements, Osteorisk calculations and quantitative ultrasound on the heel using Sonost 2000 equipment. RESULTS: 461 women were included, with mean age 60 ± 9 years, weight 67.6 ± 12.9 kg and body mass index (BMI) 28.8 ± 5.0 kg/m². Their Osteorisk classifications were: 61.0% low-risk, 28.4% medium-risk and 10.6% high-risk. Quantitative ultrasound showed 81.3% low-risk, 10.0% medium-risk and 8.7% high-risk regarding osteoporosis. Statistically significant results were observed (p < 0.001) when Osteorisk was correlated with age, years since menopause and BMI. Correlating these same variables with quantitative ultrasound, statistically significant results were observed for age (p < 0.001), years since menopause (p < 0.001) and BMI (p < 0.006). The sensitivity, specificity, negative predictive value and positive predictive value for Osteorisk were 64%, 6.7%, 89% and 30.6%, respectively. CONCLUSION: Osteorisk is a valid tool for screening for women at low risk of osteoporosis, making it possible for these women not to have to undergo densitometry.
id APM-1_0ed5d96cfe0e1b2d76e42dc38291bb9d
oai_identifier_str oai:scielo:S1516-31802008000100005
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Accuracy study on "Osteorisk": a new osteoporosis screening clinical tool for women over 50 years oldOsteoporosisBone mineral densityScreeningUltrasonographyRisk factorsCONTEXT AND OBJECTIVE: Osteoporosis is the greatest cause of quality-of-life reductions, morbidity and mortality among postmenopausal women, with growing incidence as populations age. Clinical tools like Osteorisk provide an easy-access and low-cost alternative method that helps physicians to reduce the need for dual-energy X-ray absorptiometry (DXA), the expensive gold standard examination for diagnosing osteoporosis. The aim here was to study the accuracy of Osteorisk using heel ultrasonography for bone mineral density (BMD). DESIGN AND SETTING: Cross-sectional study, at Faculdade de Medicina do ABC. METHODS: A structured questionnaire was applied to 615 postmenopausal women, with anthropometric measurements, Osteorisk calculations and quantitative ultrasound on the heel using Sonost 2000 equipment. RESULTS: 461 women were included, with mean age 60 ± 9 years, weight 67.6 ± 12.9 kg and body mass index (BMI) 28.8 ± 5.0 kg/m². Their Osteorisk classifications were: 61.0% low-risk, 28.4% medium-risk and 10.6% high-risk. Quantitative ultrasound showed 81.3% low-risk, 10.0% medium-risk and 8.7% high-risk regarding osteoporosis. Statistically significant results were observed (p < 0.001) when Osteorisk was correlated with age, years since menopause and BMI. Correlating these same variables with quantitative ultrasound, statistically significant results were observed for age (p < 0.001), years since menopause (p < 0.001) and BMI (p < 0.006). The sensitivity, specificity, negative predictive value and positive predictive value for Osteorisk were 64%, 6.7%, 89% and 30.6%, respectively. CONCLUSION: Osteorisk is a valid tool for screening for women at low risk of osteoporosis, making it possible for these women not to have to undergo densitometry.Associação Paulista de Medicina - APM2008-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100005Sao Paulo Medical Journal v.126 n.1 2008reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/S1516-31802008000100005info:eu-repo/semantics/openAccessSteiner,Marcelo LuisFernandes,César EduardoStrufaldi,RodolfoAzevedo,Lucia Helena deStephan,CristinaPompei,Luciano MeloPeixoto,Sérgioeng2008-04-14T00:00:00Zoai:scielo:S1516-31802008000100005Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2008-04-14T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Accuracy study on "Osteorisk": a new osteoporosis screening clinical tool for women over 50 years old
title Accuracy study on "Osteorisk": a new osteoporosis screening clinical tool for women over 50 years old
spellingShingle Accuracy study on "Osteorisk": a new osteoporosis screening clinical tool for women over 50 years old
Steiner,Marcelo Luis
Osteoporosis
Bone mineral density
Screening
Ultrasonography
Risk factors
title_short Accuracy study on "Osteorisk": a new osteoporosis screening clinical tool for women over 50 years old
title_full Accuracy study on "Osteorisk": a new osteoporosis screening clinical tool for women over 50 years old
title_fullStr Accuracy study on "Osteorisk": a new osteoporosis screening clinical tool for women over 50 years old
title_full_unstemmed Accuracy study on "Osteorisk": a new osteoporosis screening clinical tool for women over 50 years old
title_sort Accuracy study on "Osteorisk": a new osteoporosis screening clinical tool for women over 50 years old
author Steiner,Marcelo Luis
author_facet Steiner,Marcelo Luis
Fernandes,César Eduardo
Strufaldi,Rodolfo
Azevedo,Lucia Helena de
Stephan,Cristina
Pompei,Luciano Melo
Peixoto,Sérgio
author_role author
author2 Fernandes,César Eduardo
Strufaldi,Rodolfo
Azevedo,Lucia Helena de
Stephan,Cristina
Pompei,Luciano Melo
Peixoto,Sérgio
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Steiner,Marcelo Luis
Fernandes,César Eduardo
Strufaldi,Rodolfo
Azevedo,Lucia Helena de
Stephan,Cristina
Pompei,Luciano Melo
Peixoto,Sérgio
dc.subject.por.fl_str_mv Osteoporosis
Bone mineral density
Screening
Ultrasonography
Risk factors
topic Osteoporosis
Bone mineral density
Screening
Ultrasonography
Risk factors
description CONTEXT AND OBJECTIVE: Osteoporosis is the greatest cause of quality-of-life reductions, morbidity and mortality among postmenopausal women, with growing incidence as populations age. Clinical tools like Osteorisk provide an easy-access and low-cost alternative method that helps physicians to reduce the need for dual-energy X-ray absorptiometry (DXA), the expensive gold standard examination for diagnosing osteoporosis. The aim here was to study the accuracy of Osteorisk using heel ultrasonography for bone mineral density (BMD). DESIGN AND SETTING: Cross-sectional study, at Faculdade de Medicina do ABC. METHODS: A structured questionnaire was applied to 615 postmenopausal women, with anthropometric measurements, Osteorisk calculations and quantitative ultrasound on the heel using Sonost 2000 equipment. RESULTS: 461 women were included, with mean age 60 ± 9 years, weight 67.6 ± 12.9 kg and body mass index (BMI) 28.8 ± 5.0 kg/m². Their Osteorisk classifications were: 61.0% low-risk, 28.4% medium-risk and 10.6% high-risk. Quantitative ultrasound showed 81.3% low-risk, 10.0% medium-risk and 8.7% high-risk regarding osteoporosis. Statistically significant results were observed (p < 0.001) when Osteorisk was correlated with age, years since menopause and BMI. Correlating these same variables with quantitative ultrasound, statistically significant results were observed for age (p < 0.001), years since menopause (p < 0.001) and BMI (p < 0.006). The sensitivity, specificity, negative predictive value and positive predictive value for Osteorisk were 64%, 6.7%, 89% and 30.6%, respectively. CONCLUSION: Osteorisk is a valid tool for screening for women at low risk of osteoporosis, making it possible for these women not to have to undergo densitometry.
publishDate 2008
dc.date.none.fl_str_mv 2008-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100005
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1516-31802008000100005
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Paulista de Medicina - APM
publisher.none.fl_str_mv Associação Paulista de Medicina - APM
dc.source.none.fl_str_mv Sao Paulo Medical Journal v.126 n.1 2008
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1754209262096089088